Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
HFB301001
i
Other names:
HFB301001, HFB3010
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
HiFiBiO
Drug class:
OX40 agonist
Related drugs:
‹
ATOR-1015 (0)
BGB-A445 (0)
BMS-986178 (0)
FS120 (0)
GSK3174998 (0)
INBRX-106 (0)
INCAGN1949 (0)
MEDI6469 (0)
NKX019 (0)
NKX101 (0)
S095025 (0)
SL-279252 (0)
IBI101 (0)
PF-04518600 (0)
MOXR0916 (0)
ABBV-368 (0)
MEDI0562 (0)
ATOR-1015 (0)
BGB-A445 (0)
BMS-986178 (0)
FS120 (0)
GSK3174998 (0)
INBRX-106 (0)
INCAGN1949 (0)
MEDI6469 (0)
NKX019 (0)
NKX101 (0)
S095025 (0)
SL-279252 (0)
IBI101 (0)
PF-04518600 (0)
MOXR0916 (0)
ABBV-368 (0)
MEDI0562 (0)
›
Associations
News
Trials
Filter by
Latest
7ms
HFB-301001-01: A Study of HFB301001 in Adult Patients With Advanced Solid Tumors (clinicaltrials.gov)
P1, N=84, Active, not recruiting, HiFiBiO Therapeutics | Recruiting --> Active, not recruiting | Trial completion date: Jan 2024 --> Jan 2025 | Trial primary completion date: Jan 2024 --> Jan 2025
7 months ago
Enrollment closed • Trial completion date • Trial primary completion date • Metastases
|
BRAF (B-raf proto-oncogene)
|
BRAF V600
|
HFB301001
Share via
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login